Etiopatogenia, diagnóstico y tratamiento de la enfermedad relacionada con la IgG4

Martínez-Valle, Fernando; Orozco-Gálvez, Olimpia; Fernández-Codina, Andreu.
Med. clín (Ed. impr.) ; 151(1): 18-25, jul. 2018. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-173745

Documentos relacionados

  1. Comprehensive overview of autoantibody isotype and subclass distribution.
  2. Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy.
  3. [Chinese expert consensus on the diagnosis and treatment of IgG<sub>4</sub> related diseases].
  4. Autoantibody subclass predominance is not driven by aberrant class switching or impaired B cell development.
  5. [IgG4-related disease: what do we know after 20 years].
  6. Glycosylation in Autoimmune Diseases.
  7. Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.
  8. Signaling by Antibodies: Recent Progress.
  9. Immunological Role of IgG Subclasses.
  10. Autoimmune pancreatitis ­ a surgical mistake?